WO2024116027A1 - Hair care composition, a formulation and method of treating and managing hair - Google Patents
Hair care composition, a formulation and method of treating and managing hair Download PDFInfo
- Publication number
- WO2024116027A1 WO2024116027A1 PCT/IB2023/061790 IB2023061790W WO2024116027A1 WO 2024116027 A1 WO2024116027 A1 WO 2024116027A1 IB 2023061790 W IB2023061790 W IB 2023061790W WO 2024116027 A1 WO2024116027 A1 WO 2024116027A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- composition
- blend
- acid
- cysteine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 328
- 210000004209 hair Anatomy 0.000 title claims abstract description 273
- 238000009472 formulation Methods 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims description 37
- 150000001413 amino acids Chemical class 0.000 claims abstract description 189
- 108060008539 Transglutaminase Proteins 0.000 claims abstract description 73
- 102000003601 transglutaminase Human genes 0.000 claims abstract description 73
- 229940024606 amino acid Drugs 0.000 claims description 186
- 235000001014 amino acid Nutrition 0.000 claims description 186
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 70
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 58
- 235000014705 isoleucine Nutrition 0.000 claims description 58
- 229960000310 isoleucine Drugs 0.000 claims description 58
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 58
- 239000004475 Arginine Substances 0.000 claims description 55
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 55
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 55
- 235000004279 alanine Nutrition 0.000 claims description 55
- 229960003767 alanine Drugs 0.000 claims description 55
- 235000009697 arginine Nutrition 0.000 claims description 55
- 229960003121 arginine Drugs 0.000 claims description 55
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 55
- 235000018417 cysteine Nutrition 0.000 claims description 53
- 229960002433 cysteine Drugs 0.000 claims description 53
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 53
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 52
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 52
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 52
- 235000013930 proline Nutrition 0.000 claims description 52
- 229960002429 proline Drugs 0.000 claims description 52
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 49
- 235000002374 tyrosine Nutrition 0.000 claims description 49
- 229960004441 tyrosine Drugs 0.000 claims description 49
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 49
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 47
- 235000008729 phenylalanine Nutrition 0.000 claims description 47
- 229960005190 phenylalanine Drugs 0.000 claims description 47
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 47
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 45
- 235000014304 histidine Nutrition 0.000 claims description 45
- 229960002885 histidine Drugs 0.000 claims description 45
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 45
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 41
- 235000006109 methionine Nutrition 0.000 claims description 41
- 229930182817 methionine Natural products 0.000 claims description 41
- 229960004452 methionine Drugs 0.000 claims description 41
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 40
- 239000002738 chelating agent Substances 0.000 claims description 36
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 34
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 34
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 34
- 239000011976 maleic acid Substances 0.000 claims description 34
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 33
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 33
- 235000013922 glutamic acid Nutrition 0.000 claims description 33
- 229960002989 glutamic acid Drugs 0.000 claims description 33
- 239000004220 glutamic acid Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 29
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 29
- 235000005772 leucine Nutrition 0.000 claims description 29
- 229960003136 leucine Drugs 0.000 claims description 29
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 27
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 27
- 235000014393 valine Nutrition 0.000 claims description 27
- 229960004295 valine Drugs 0.000 claims description 27
- 239000004474 valine Substances 0.000 claims description 27
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 22
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 22
- 239000004473 Threonine Substances 0.000 claims description 22
- 235000008521 threonine Nutrition 0.000 claims description 22
- 229960002898 threonine Drugs 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 230000008439 repair process Effects 0.000 claims description 17
- 239000004471 Glycine Substances 0.000 claims description 16
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 16
- 235000003704 aspartic acid Nutrition 0.000 claims description 16
- 229960005261 aspartic acid Drugs 0.000 claims description 16
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 16
- 229960002449 glycine Drugs 0.000 claims description 16
- 230000009467 reduction Effects 0.000 claims description 12
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 10
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 10
- 230000003750 conditioning effect Effects 0.000 claims description 10
- 239000002537 cosmetic Substances 0.000 claims description 10
- 229960004799 tryptophan Drugs 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 8
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 7
- 230000003700 hair damage Effects 0.000 claims description 6
- 210000004761 scalp Anatomy 0.000 claims description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
- 229960003646 lysine Drugs 0.000 claims description 5
- 235000018977 lysine Nutrition 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 229960001153 serine Drugs 0.000 claims description 5
- 235000004400 serine Nutrition 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000002453 shampoo Substances 0.000 claims description 5
- 206010019049 Hair texture abnormal Diseases 0.000 claims description 4
- 102000011782 Keratins Human genes 0.000 claims description 4
- 108010076876 Keratins Proteins 0.000 claims description 4
- 239000003212 astringent agent Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- -1 perfuming Substances 0.000 claims description 4
- 230000008707 rearrangement Effects 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- NIONDZDPPYHYKY-SNAWJCMRSA-N (2E)-hexenoic acid Chemical compound CCC\C=C\C(O)=O NIONDZDPPYHYKY-SNAWJCMRSA-N 0.000 claims description 2
- BSSNZUFKXJJCBG-UPHRSURJSA-N (z)-but-2-enediamide Chemical compound NC(=O)\C=C/C(N)=O BSSNZUFKXJJCBG-UPHRSURJSA-N 0.000 claims description 2
- MGDKBCNOUDORNI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;potassium Chemical compound [K].[K].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O MGDKBCNOUDORNI-UHFFFAOYSA-N 0.000 claims description 2
- 239000004909 Moisturizer Substances 0.000 claims description 2
- 239000003082 abrasive agent Substances 0.000 claims description 2
- 230000001166 anti-perspirative effect Effects 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- 239000003213 antiperspirant Substances 0.000 claims description 2
- 239000002216 antistatic agent Substances 0.000 claims description 2
- ROPXFXOUUANXRR-YPKPFQOOSA-N bis(2-ethylhexyl) (z)-but-2-enedioate Chemical compound CCCCC(CC)COC(=O)\C=C/C(=O)OCC(CC)CCCC ROPXFXOUUANXRR-YPKPFQOOSA-N 0.000 claims description 2
- 239000004067 bulking agent Substances 0.000 claims description 2
- 239000004075 cariostatic agent Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 230000007797 corrosion Effects 0.000 claims description 2
- 238000005260 corrosion Methods 0.000 claims description 2
- 239000006184 cosolvent Substances 0.000 claims description 2
- 239000003398 denaturant Substances 0.000 claims description 2
- 239000002781 deodorant agent Substances 0.000 claims description 2
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 210000000720 eyelash Anatomy 0.000 claims description 2
- 239000000834 fixative Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 239000000118 hair dye Substances 0.000 claims description 2
- 230000003779 hair growth Effects 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 238000001802 infusion Methods 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000004611 light stabiliser Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 230000002101 lytic effect Effects 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 239000003605 opacifier Substances 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 230000001012 protector Effects 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 claims description 2
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 claims description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- 239000003139 biocide Substances 0.000 claims 1
- 210000004919 hair shaft Anatomy 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 238000010976 amide bond formation reaction Methods 0.000 abstract description 6
- 230000034005 thiol-disulfide exchange Effects 0.000 abstract description 6
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 58
- 238000002360 preparation method Methods 0.000 description 26
- 238000011282 treatment Methods 0.000 description 18
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 16
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 12
- 230000006378 damage Effects 0.000 description 12
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 10
- 238000004061 bleaching Methods 0.000 description 9
- 241000244317 Tillandsia usneoides Species 0.000 description 8
- 238000004626 scanning electron microscopy Methods 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000001530 fumaric acid Substances 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- BNTPVRGYUHJFHN-UHFFFAOYSA-N oct-2-enedioic acid Chemical compound OC(=O)CCCCC=CC(O)=O BNTPVRGYUHJFHN-UHFFFAOYSA-N 0.000 description 5
- HSBSUGYTMJWPAX-HNQUOIGGSA-N trans-2-hexenedioic acid Chemical compound OC(=O)CC\C=C\C(O)=O HSBSUGYTMJWPAX-HNQUOIGGSA-N 0.000 description 5
- HSBSUGYTMJWPAX-UHFFFAOYSA-N trans-Deltaalpha-Dihydromuconsaeure Natural products OC(=O)CCC=CC(O)=O HSBSUGYTMJWPAX-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003745 detangling effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000003752 improving hair Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- IEPRKVQEAMIZSS-WAYWQWQTSA-N Diethyl maleate Chemical compound CCOC(=O)\C=C/C(=O)OCC IEPRKVQEAMIZSS-WAYWQWQTSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- UNZOESWLBMZBEY-JEIPZWNWSA-N bis(16-methylheptadecyl) (e)-but-2-enedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)\C=C\C(=O)OCCCCCCCCCCCCCCCC(C)C UNZOESWLBMZBEY-JEIPZWNWSA-N 0.000 description 1
- VQLYBLABXAHUDN-UHFFFAOYSA-N bis(4-fluorophenyl)-methyl-(1,2,4-triazol-1-ylmethyl)silane;methyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1.C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 VQLYBLABXAHUDN-UHFFFAOYSA-N 0.000 description 1
- ABBZJHFBQXYTLU-UHFFFAOYSA-N but-3-enamide Chemical compound NC(=O)CC=C ABBZJHFBQXYTLU-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- TVWTZAGVNBPXHU-NXVVXOECSA-N dioctyl (z)-but-2-enedioate Chemical compound CCCCCCCCOC(=O)\C=C/C(=O)OCCCCCCCC TVWTZAGVNBPXHU-NXVVXOECSA-N 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- MSJMDZAOKORVFC-UAIGNFCESA-L disodium maleate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C/C([O-])=O MSJMDZAOKORVFC-UAIGNFCESA-L 0.000 description 1
- IZZSMHVWMGGQGU-UHFFFAOYSA-L disodium;2-methylidenebutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(=C)C([O-])=O IZZSMHVWMGGQGU-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Definitions
- the present disclosure relates to field of cosmetics.
- the present disclosure particularly relates to a composition having excellent hair care effect.
- the composition provides for effective management and treatment of hair.
- the disclosure relates to method of preparing the composition and method of managing and treating hair.
- human hair is composed of three layers, cuticle, the cortex and the medulla.
- the cuticle layer is the outermost layers and has the functions of coating and protecting cortex, and undamaged cuticle layer of the healthy hair has smooth surface and the functions of refracting light and reducing friction among hairs.
- Hair is susceptible to external environmental influences, in particular, hair damage due to dry cold wind, indoor heating, excessive combing stress, malnutrition and insufficient sleep.
- people regard hair as a fashion, and the hair is frequently subjected to numerous hair treatment, such as dyeing, perming, bleaching, excessive use of hair dressing products, and increased use of hair dryers for long time, which is known to frequently cause hair damage.
- the present disclosure provides a composition that solves the problem noted in the existing hair care composition and hair management and/or treatment techniques and capable of repairing damaged hair by multiple mechanisms simultaneously and synergistically.
- the present disclosure describes a hair care composition that has excellent hair management and treatment property.
- the hair care composition affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acids in the hair shaft, while managing and treating the hair, unlike the conventional hair care composition and treatment techniques.
- the present disclosure describes a composition comprising monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids.
- the present disclosure further describes a method of preparing the composition, said method comprises- mixing the monounsaturated carboxylic acid or its derivatives, the transglutaminase and the amino acid blend comprising at least 5 amino acids to obtain the composition.
- the present disclosure further describes a formulation comprising effective amount of the composition described above.
- the present disclosure further describes a method for managing and/or treating hair, said method comprises applying the composition or the formulation to hair for managing and/or treating the hair.
- Figure 1 provides Scanning electron microscopy (SEM) analysis images (500X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
- SEM Scanning electron microscopy
- Figure 2 provides Scanning electron microscopy (SEM) analysis images (1000X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
- SEM Scanning electron microscopy
- Figure 3 provides Fourier-transform infrared spectroscopy (FT-IR) analysis plot of- i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
- FT-IR Fourier-transform infrared spectroscopy
- 'about' as used herein when referring to a measurable value such as a parameter, an amount, a temporal duration, and the like, is meant to encompass variations of ⁇ 10% or less, preferably ⁇ 5% or less, more preferably ⁇ 1% or less and still more preferably ⁇ 0.1% or less of and from the specified value, insofar such variations are appropriate to perform the present disclosure. It is to be understood that the value to which the modifier 'about' refers is itself also specifically, and preferably disclosed.
- 'treatment', 'treating of hair' or 'hair treatment' refers to cosmetic treatment, which does not involve any kind of therapy.
- the treatment or treating described herein refers to application of the composition of the present disclosure for purely cosmetic purposes and that there is no involvement of any kind of therapy.
- 'managing/management', 'hair managing/management',' or 'managing/management of hair' refers to application of the composition of present disclosure for purely cosmetic and cosmeceutical purposes involving hair detangling, hair fizz control, hair conditioning, hair nourishment, prevention of hair drying, increase in hair volume, cuticle sealing, strengthening of hair, improving hair smoothness, decreasing hair splits and softening of hair. However, does not involve any kind of therapy.
- the present disclosure describes a hair care composition.
- the hair care composition of the present disclosure provides for excellent hair treatment and hair management without causing any negative and/or side effect.
- the hair care composition of the present disclosure affects and/or works on multiple targets synergistically in the hair.
- the hair care composition simultaneously provides for disulphide bond formation, amide bond formation and boosting the level of amino acids in hair shaft, unlike known or commercially available hair care composition or treatment techniques which affect single targets.
- the hair care composition comprises monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids. In some embodiments of the present disclosure, the hair care composition comprises monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids.
- the monounsaturated carboxylic acid is selected from a group comprising itaconic acid, maleic acid, patenedioic acid, hexedioic acid, hexenoic acid, octenedioic acid and any combinations thereof.
- derivatives of the monounsaturated carboxylic acid are selected from a group comprising ester of monounsaturated carboxylic acid, isomer of monounsaturated carboxylic acid, amide of monounsaturated carboxylic acid, salt of monounsaturated carboxylic acid and any combinations thereof.
- the ester of the monounsaturated carboxylic acid is selected from a group comprising, Bis(2-ethylhexyl) maleate, dicaprylyl maleate, diethyl 2-butenedioate, diisostearyl fumarate and any combinations thereof.
- the amide of the monounsaturated carboxylic acid is selected from a group comprising maleamide, crotonamide, 3-butenamide and any combinations thereof.
- the salts of the monounsaturated carboxylic acid is selected from a group comprising Disodium maleate, disodium fumarate, sodium itaconate and any combinations thereof.
- the isomer of the monounsaturated carboxylic acid is selected from a group comprising Fumaric acid, mesaconic acid, citraconic acid and any combinations thereof.
- the monounsaturated carboxylic acid is in an amount ranging from about 1% to 15%, including all the values in the range, for instance,
- derivatives of the monounsaturated carboxylic acid are in an amount ranging from about 1% to 15%, including all the values in the range, for instance, 1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
- the transglutaminase is selected from a group comprising TGI, TG2, TG3, TG4, TG5, TG6, TG7, Plasma TG and any combinations thereof.
- the transglutaminase is in an amount ranging from about 0.001% to 1%, including all the values in the range, for instance, 0.002%, 0.003%, 0.004%, 0.005% and so on and so forth.
- the amino acid blend comprises amino acids selected from a group comprising. Cysteine, Serine, Glutamic Acid, Threonine, Glycine, Leucine, Valine, Arginine, Aspartic Acid, Alanine, Proline, Isoleucine, Tyrosine, Phenylalanine, Histidine, Methionine, Lysine, Tryptophan and any combinations thereof.
- the amino acid blend is selected from a group comprising blend of Alanine, Arginine, Proline, Tyrosine and Cysteine; blend of Cysteine, Histidine, Phenylalanine, Methionine and Isoleucine; blend of Glutamic acid, Arginine, Valine, Leucine and Alanine; blend of Aspartic Acid, Alanine, Proline, Arginine and Methionine; blend of Serine, Threonine, Glycine, Lysine and Tryptophan; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine and Isoleucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine and Phenylalanine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine and Phenylalanine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and His
- the amino acid blend is in an amount ranging from about 0.05% to 10%, including all the values in the range, for instance, 0.06%, 0.07%, 0.08%, 0.09% and so on and so forth.
- amino acids are present in same proportion.
- amino acids in the amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids, the amino acids are present in different proportions.
- amino acids are present in different proportions as present in virgin hair.
- the composition comprises solvent includes but it is not limited to water.
- the solvent is present in sufficient amount for making the composition, i.e., quantum sufficit (q.s.).
- the composition comprises water in sufficient amount for making the composition, i.e., quantum sufficit (q.s.).
- the composition comprises about 1% to about 15% of the monounsaturated carboxylic acid or its derivative; about 0.001% to 1% of the transglutaminase; about 0.05% to 10% of amino acid blend comprising at least 5 amino acids and solvent is present in sufficient quantity.
- the composition comprises chelating agent.
- the chelating agent is selected from a group comprising Ethylenediaminetetraacetic acid, Disodium ethylenediaminetetraacetic acid, Trisodium Ethylenediamine Disuccinate, Dipotassium ethylenediaminetetraacetic acid, Diethyl oxalate and any combinations thereof.
- the chelating agent is present in an amount ranging from about 0.05% to 1%, including all the values in the range, for instance, 0.06%. 0.07%, 0.08%, 0.09% and so on and so forth.
- the chelating agent is present in an amount ranging from about 0.05% to 0.1%. In an embodiment, the chelating agent is present in an amount of about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09% or about 0.1%.
- the composition has pH ranging from about 2 to 11, including all the values in the range, for instance, 2.1, 2.2, 2.3, 2.4 and so on and so forth.
- the inventors of the present application have particularly identified that the combination of monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids provides for improved hair treatment and hair management, which is not observed while using components individually or a composition comprising combination of two components, respectively.
- composition comprising combination of monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids, affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acid in hair shaft, which is not the case when the components are employed individually or a composition comprising combination of two components.
- the figures 1 and 2 describes improved effect (as per SEM analysis) of the composition of the present disclosure in hair management and treatment, wherein surprising effect of the composition can be noted vis-a-vis individual components and composition comprising combination of two components, respectively.
- Figure 3 describes improved effect (as per FT-IR analysis) of the composition of the present disclosure in hair management and treatment over individual components and composition comprising combination of two components, respectively.
- the present disclosure further describes a method of preparing the composition described above.
- the method of preparing the composition comprises- mixing the monounsaturated carboxylic acid or its derivative, the transglutaminase and the amino acid blend comprising at least 5 amino acids.
- the method of preparing the composition comprises- mixing the monounsaturated carboxylic acid or its derivative, the transglutaminase and the amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids.
- the method of preparing the composition comprises: a) adding the monounsaturated carboxylic or its derivative to a mixture comprising the solvent and the chelating agent, followed by stirring; b) adding the transglutaminase, followed by stirring; and c) adding the amino acid blend comprising at least 5 amino acids and stirring to obtain the composition.
- the stirring in the step a) is carried out at a temperature ranging from about 20 °C to 60 °C, including all the values in the range, for instance, 21 °C, 22 °C, 23 °C, 24 °C and so on and so forth, for a duration ranging from about 1 minute to 90 minutes, including all the values in the range, for instance, 2 minutes, 3 minutes, 4 minutes, 5 minutes and so on and so forth.
- the stirring is carried out until clear solution is obtained.
- the stirring in the step b) is carried out at a temperature ranging from about 20 °C to 60 °C, including all the values in the range, for instance, 21 °C, 22 °C, 23 °C, 24 °C and so on and so forth, for a duration ranging from about 1 minute to 60 minutes, including all the values in the range, for instance, 2 minutes, 3 minutes, 4 minutes, 5 minutes and so on and so forth.
- the stirring is carried out until clear solution is obtained.
- the stirring in the step c) is carried out at a temperature ranging from about 20 °C to 60 °C, including all the values in the range, for instance, 21 °C, 22 °C, 23 °C, 24 °C and so on and so forth, for a duration ranging from about 1 minute to 90 minutes, including all the values in the range, for instance, 2 minutes, 3 minutes, 4 minutes, 5 minutes and so on and so forth.
- the pH of the solution upon adding the monounsaturated carboxylic acid or its derivative, is maintained in a range of about 2 to 11, including all the values in the range, for instance, 2.1, 2.2, 2.3, 2.4 and so on and so forth.
- the present disclosure further relates to a formulation comprising the composition described above in an effective amount.
- the formulation comprises the composition in an effective amount and excipient.
- the composition in the formulation, is present in an amount ranging from about 1% to 25%, including all the values in the range, for instance, 1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
- the excipient in the formulation, is present in an amount ranging from about 1% to 99%, including all the values in the range, for instance, 0.2%, 0.3%, 0.4%, 0.5% and so on and so forth.
- the excipient is selected from a group comprising Corrosion Inhibitors, Cosmetic Astringents, Denaturants, Deodorant Agents, Surfactant, Opacifiers, Chelating Agent, Emulsifier, Preservative, Thickeners, Emollient, Cosolvent, Abrasives, Anticaking Agent, Anticaries Agents, Antifoaming Agents, Antiperspirants, Antistatic Agents, Artificial Nail Builders, Depilating Agents, Bulking Agents, Colorants, Perfuming, Dispersing Agents, occlusive, Astringents, Emulsion Stabilizers, Epilating Agents, Exfoliants, Eyelash Conditioning Agents, Film Formers, Flavoring Agents, Fragrance Ingredients, Hair Colorants, Hair Conditioning Agents, Hair Fixatives, Hair Waving/Straightening Agents, Humectants, Light Stabilizers, Lytic Agents, Nail Conditioning Agents, Opacifying Agents, Oxidizing Agents, gel
- the formulation comprises solvent including but it is not limited to water.
- the solvent is present in sufficient amount for making the composition, i.e., quantum sufficit (q.s.).
- the formulation has pH ranging from about 2 to 11, including all the values in the range, for instance, 2.1, 2.2, 2.3, 2.4 and so on and so forth.
- the formulation is selected from a group comprising Hair Mask, Hair Cream, Hair Spray, Hair Serum, Hair Colour, Hair Lotion, Hair Wax, Hair Gel, Hair Balm, Hair Mousse, Hair Tonic, Hair Moisturizer, Hair Cleanser, Hair Butter, Hair Colour Remover, Hair Solution, Hair Pomade, Hair Volumizer, Hair Clay, Hair Cream, Hair Oil, Hair Stylers, Hair Heat Protector, Hair Conditioning Mask, Hair Root Pump, Dry Shampoo, Hair Texturizer, Hair Curl Retentioner, Heena Powder, Hair Growth Serum, Hair Drops, Hair Scalp Maintenance, Hair Scalp Exfoliator, Hair Scalp Scrub, Shampoo Bar, Conditioner Bar, Hair Concentrates and Hair Infusion.
- the formulation of the present disclosure provides for improved hair management and hair treatment.
- the formulation affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acid in hair shaft.
- the formulation provides excellent hair management and treatment.
- the present disclosure further relates to method for managing and/or treating hair.
- the method for managing and/or treating hair comprises- applying the composition described above or the formulation described above to hair for managing and/or treating the hair.
- the managing and/or treating of hair comprises at least one of hair damage repair, free cysteine rearrangement, amide bond repair, disulphide bond repair, keratin repair and any combinations thereof.
- the managing and/or treating of hair comprises hair damage repair, free cysteine rearrangement, amide bond repair, disulphide bond repair and keratin repair.
- the composition in the method of managing and/or treating hair, is employed at a concentration ranging from about 1% to 25%, including all the values the range, for instance, 1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
- the managed and/or treated hair shows up to 95% reduction in free cysteine when compared to bleached hair. In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in free cysteine in the range of about 13% to 95%, including all the values in the range, for instance, 13%, 14%, 15%, 16% and so on and so forth, when compared to bleached hair.
- the managed and/or treated hair shows reduction in free cysteine in the range of about 13% to 95%, including all the values in the range, for instance, 13%, 14%, 15%, 16% and so on and so forth, when compared to hair not applied with the composition or the formulation of the present disclosure.
- the managed and/or treated hair shows up to about 81% reduction in combining force in wet hair when compared to bleached hair.
- the managed and/or treated hair shows reduction in combining force in wet hair in the range of about 28% to 81%, including all the values in the range, for instance, 29%, 30%, 31%, 32% and so on and so forth, when compared to bleached hair.
- the managed and/or treated hair shows reduction in combining force in wet hair in the range of about 28% to 81%, including all the values in the range, for instance, 29%, 30%, 31%, 32% and so on and so forth, when compared to hair not applied with the composition or the formulation of the present disclosure.
- the managed and/or treated hair shows about 87% reduction in combining force in dry hair when compared to bleached hair.
- the managed and/or treated hair shows reduction in combining force in dry hair in the range of about 46% to 87%, including all the values in the range, for instance, 47%, 48%, 49%, 50% and so on and so forth, when compared to bleached hair.
- the managed and/or treated hair shows reduction in combining force in dry hair in the range of about 46% to 87%, including all the values in the range, for instance, 47%, 48%, 49%, 50% and so on and so forth, when compared to hair not applied with the composition or the formulation of the present disclosure.
- the managed and/or treated hair has increased tensile stress up to 48% when compared to bleached hair.
- the managed and/or treated hair has tensile stress in the range of about 6% to 48%, including all the values in the range, for instance, 7%, 8%, 9%, 10% and so on and so forth.
- the managed and/or treated hair applied with the composition or the formulation of the present disclosure has higher tensile stress when compared to bleached hair.
- the managed and/or treated hair shows increased tensile stress in the range of about 6% to 48%, including all the values in the range, for instance, 7%, 8%, 9%, 10% and so on and so forth.
- the managed and/or treated hair applied with the composition or the formulation of the present disclosure has higher tensile stress when compared to hair not applied with the composition or the formulation of the present disclosure.
- the Figure 1 provides Scanning electron microscopy (SEM) analysis images (500X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hairtreated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii.
- SEM Scanning electron microscopy
- hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure From the images, it can be noted that the bleaching of hair caused significant damage in the hair cuticles. It can be noted that when bleached hair was treated with individual components of the composition, hair showed negligible recovery from the damages caused by bleaching. Further, it can be noted that when the bleached hair was treated with composition comprising combination of two components there was only marginal recovery from the damages caused by bleaching. However, it was surprisingly noted that the bleached hair treated with the composition of the present disclosure showed significant recovery from the damages caused by bleaching [see figure 1 (viii)]. It can be noted that cuticles of the hair were found be repaired with smooth texture. Thus, clearly establishing that the composition of the present disclosure has synergistic effect in treating and/or managing hair.
- monounsaturated carboxylic acid e.g., maleic acid
- transglutaminase
- the Figure 2 provides Scanning electron microscopy (SEM) analysis images (1000X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hairtreated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii.
- SEM Scanning electron microscopy
- hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure From the images, it can be noted that the bleaching of hair caused significant damage in the hair cuticles. It can be noted that when bleached hair was treated with individual components of the composition, hair showed negligible recovery from the damages caused by bleaching. Further, it can be noted that when the bleached hair was treated with composition comprising combination of two components there was only marginal recovery from the damages caused by bleaching. However, it was surprisingly noted that the bleached hair treated with the composition of the present disclosure showed significant recovery from the damages caused by bleaching [see figure 2 (viii)]. It can be noted that cuticles of the hair were found be repaired with smooth texture. Thus, clearly establishing that the composition of the present disclosure has synergistic effect in treating and/or managing hair.
- monounsaturated carboxylic acid e.g., maleic acid
- transglutaminase
- the Figure-3 provides Fourier-transform infrared spectroscopy (FT-IR) analysis plot of- i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hairtreated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii.
- FT-IR Fourier-transform infrared spectroscopy
- monounsaturated carboxylic acid e.g., maleic acid
- transglutaminase e.g., transglutaminase
- hair treated with the composition of the present disclosure From the FT-IR spectrum, it can be noted that, the bleached hair showed a peak at 1042 cm 1 which attributes to the presence of cysteic acid. Furthermore, same peak was observed between 1045-1040 cm 1 in the FT-IR spectrum of hair treated with individual components of the composition and combination of two components. However, this peak is absent in the spectra of hair treated with the composition of the present disclosure suggested absence of cysteic acid.
- composition, the formulation and the method of managing and treating hair of the present disclosure provides for the following advantages.
- composition and/or the formulation affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acid in hair shaft.
- composition and/or the formulation of the present disclosure provides for hair damage repair, free cysteine rearrangement, amide bond repair, disulphide bond repair, keratin repair, hair detangling, frizz control and hair softness.
- Example 16 Preparation of the Composition About 96.7 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 1 gm of Itaconic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.2 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threonine was added and stirred to obtain the composition.
- amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threonine was added and stirred to obtain the composition.
- Example 23 Preparation of the Composition About 93.3 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 5 gm of Fumaric acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.8 gm transglutaminase was added, followed by stirring until clear solution was obtained.
- amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan was added and stirred to obtain the composition.
- amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan was added and stirred to obtain the composition.
- the hair is treated with- i. the composition of the present disclosure; ii. individual components (maleic acid, amino acid blend comprising at least 5 amino acids, transglutaminase, respectively); and iii. composition comprising combination of two components, independently- a) maleic acid and amino acid blend comprising at least two amino acids b) transglutaminase and amino acid blend comprising at least two amino acids; and c) maleic acid and transglutaminase bleached was used control
- the data in Table 1 demonstrates that the hair treated with the composition of the present disclosure has significantly reduced cysteine content when compared to hair treated with individual components and hair treated with composition comprising combination of two components (SI. No. 2, 3 and 4). From the data in the Table 1 it can be inferred that the composition of the present disclosure has higher efficacy to keep the disulfide bond aligned and intact in the hair fibres, thus leading to significantly reduced free cysteine content, when compared to composition comprising combination of two components. According to scanning electron microscopy, no effect was noted when individual components for the composition were applied separately.
- Combining force represents cuticle alignment of hair fibres.
- Lower the combining force means more aligned unidirectional cuticle, i.e., improved managing of hair.
- Tensile stress or break stress represents overall strength of the hair fibres. Higher the tensile stress/ break stress means higher the tensile strength and less fragility of hair fibres. Table 3:
- Figure 3 shows FT-IR spectrums of- i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
- monounsaturated carboxylic acid e.g., maleic acid
- transglutaminase e.g., maleic acid
- Table 4 provides peaks noted in the FT-IR spectrum along with their description
- Table 4 i.
- the FT-IR spectrum of bleached hair and hair treated with individual components and composition comprising combination of two components showed a peak between 1115-1089 cm 1 which represent conversion of free cysteine to its sulphur monoxide derivative. While the hair treated with the composition of the present disclosure did not show peak between 1115-1089 cm 1 along with the cysteic acid peak ( ⁇ 1040 cm ) as mentioned above. This implying that there was no conversion of free cysteine to cysteic acid in the hair treated with the composition of present disclosure. iii.
- the FT-IR spectrum of bleached hair and hair treated with the individual components and composition comprising combination of two components showed a sharp peak between 1739-1738 cm 1 which represents the deformation of amide bonds.
- the intensity of this peak decreased drastically in the FT-IR spectra of hair treated with the composition of the present disclosure, implying that there was insignificant or no amide bond deformation.
- the FT-IR spectrum of bleached hair and hair treated with individual components and a composition comprising combination of two components showed peaks between 1388-1365 & 1220-1215 cm 1 which represent the presence of SO2 functionality that is due to the conversion of free cysteine to cysteic acid in the hair.
- the intensity of these peaks decreased significantly in the FT-IR spectra of hair treated with the composition of the present disclosure, implying that there was remarkably less conversion of free cysteine to cysteic acid.
- Figures 1 and 2 provides SEM analysis images (500X and 1000X magnification, respectively) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
- Bleached hair showed damaged cuticles. Hair treated with individual components and composition comprising combination of two components continued to show damaged cuticles, respectively.
- Hair treated with the composition of the present disclosure showed complete cuticle repair.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cosmetics (AREA)
Abstract
The present disclosure relates to hair care composition having excellent hair care effect. The composition comprises monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids. The present disclosure also relates to a formulation comprising the composition. The composition and the formulation of the present disclosure affects and/or works on multiple targets leading to disulphide bond formation, amide bond formation and boosting the level of amino acids in hair shaft, simultaneously.
Description
“HAIR CARE COMPOSITION, A FORMULATION AND METHOD OF TREATING AND
MANAGING HAIR”
TECHNICAL FIELD
The present disclosure relates to field of cosmetics. The present disclosure particularly relates to a composition having excellent hair care effect. The composition provides for effective management and treatment of hair. The disclosure relates to method of preparing the composition and method of managing and treating hair.
BACKGROUND OF THE DISCLOSURE
Generally, human hair is composed of three layers, cuticle, the cortex and the medulla. The cuticle layer is the outermost layers and has the functions of coating and protecting cortex, and undamaged cuticle layer of the healthy hair has smooth surface and the functions of refracting light and reducing friction among hairs.
Hair is susceptible to external environmental influences, in particular, hair damage due to dry cold wind, indoor heating, excessive combing stress, malnutrition and insufficient sleep. In addition, currently, people regard hair as a fashion, and the hair is frequently subjected to numerous hair treatment, such as dyeing, perming, bleaching, excessive use of hair dressing products, and increased use of hair dryers for long time, which is known to frequently cause hair damage.
When hair is damaged by various physical, chemical or environmental factors, cuticle damage of hair and loss of protein and lipid in the hair is caused.
Further, when cosmetic compositions are applied to hair shaft to improve hair appearance by providing cleansing, conditioning, lustre and strength to the hair fibre, it is noted that integrity of hair fibre is affected by multiple mechanisms, such as altering hydrogen bonds and salt bridges, hydrolyzing amide bonds and rupturing the disulfide bonds present in the hair shaft. Damage of hair due to destruction in different types of bonds in the hair fibre tends to lose its strength from any point between the root to tip.
Furthermore, the cosmetic composition and techniques/methods available for treatment of damaged hair or for managing hair, work through single mechanism and lack the comprehensive approach while managing and treating the hair shaft, such as amide bond and disulphide bond repair simultaneously.
Thus, there is a need for a hair care composition that can provide comprehensive approach while managing and treating hair and that can address the limitations noted in the existing hair care composition and treatments.
The present disclosure provides a composition that solves the problem noted in the existing hair care composition and hair management and/or treatment techniques and capable of repairing damaged hair by multiple mechanisms simultaneously and synergistically.
STATEMENT OF THE DISCLOSURE
Accordingly, the present disclosure describes a hair care composition that has excellent hair management and treatment property. The hair care composition affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acids in the hair shaft, while managing and treating the hair, unlike the conventional hair care composition and treatment techniques.
The present disclosure describes a composition comprising monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids.
The present disclosure further describes a method of preparing the composition, said method comprises- mixing the monounsaturated carboxylic acid or its derivatives, the transglutaminase and the amino acid blend comprising at least 5 amino acids to obtain the composition.
The present disclosure further describes a formulation comprising effective amount of the composition described above.
The present disclosure further describes a method for managing and/or treating hair, said method comprises applying the composition or the formulation to hair for managing and/or treating the hair.
BRIEF DESCRIPTION OF THE ACCOMPANYING FIGURES
In order that the present disclosure may be readily understood and put into practical effect, reference will now be made to exemplary embodiments as illustrated with reference to the accompanying figures. The figures together with detailed description below, are incorporated in and form part of the specification, and serve to further illustrate the embodiments and explain various principles and advantages, where:
Figure 1 provides Scanning electron microscopy (SEM) analysis images (500X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
Figure 2 provides Scanning electron microscopy (SEM) analysis images (1000X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
Figure 3 provides Fourier-transform infrared spectroscopy (FT-IR) analysis plot of- i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated
carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
DETAILED DESCRIPTION OF THE DISCLOSURE
Unless otherwise defined, all terms used in the disclosure, including technical and scientific terms, have meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. By means of further guidance, term definitions are included for better understanding of the present disclosure.
As used herein, the singular forms 'a', 'an' and 'the' include both singular and plural referents unless the context clearly dictates otherwise.
The term 'comprising', 'comprises' or 'comprised of' as used herein are synonymous with 'including', 'includes', 'containing' or 'contains' and are inclusive or open-ended and do not exclude additional, non-recited members, elements or method steps.
The recitation of numerical ranges by endpoints includes all numbers and fractions subsumed within the respective ranges, as well as the recited endpoints.
The term 'about' as used herein when referring to a measurable value such as a parameter, an amount, a temporal duration, and the like, is meant to encompass variations of ±10% or less, preferably ±5% or less, more preferably ±1% or less and still more preferably ±0.1% or less of and from the specified value, insofar such variations are appropriate to perform the present disclosure. It is to be understood that the value to which the modifier 'about' refers is itself also specifically, and preferably disclosed.
Reference throughout this specification to 'some embodiments', 'one embodiment' or 'an embodiment' means that a particular feature, structure or characteristic described in connection with the embodiment may be included in at least one embodiment of the present disclosure, thus, the appearances of the phrases 'in some embodiments', 'in one embodiment' or 'in an embodiment' in various places throughout this specification may not
necessarily all refer to the same embodiment. It is appreciated that certain features of the disclosure, which are for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the disclosure, which are, for brevity described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination.
As used herein, 'treatment', 'treating of hair' or 'hair treatment' refers to cosmetic treatment, which does not involve any kind of therapy. In other words, the treatment or treating described herein refers to application of the composition of the present disclosure for purely cosmetic purposes and that there is no involvement of any kind of therapy.
As used herein, 'managing/management', 'hair managing/management',' or 'managing/management of hair' refers to application of the composition of present disclosure for purely cosmetic and cosmeceutical purposes involving hair detangling, hair fizz control, hair conditioning, hair nourishment, prevention of hair drying, increase in hair volume, cuticle sealing, strengthening of hair, improving hair smoothness, decreasing hair splits and softening of hair. However, does not involve any kind of therapy.
The present disclosure describes a hair care composition.
The hair care composition of the present disclosure provides for excellent hair treatment and hair management without causing any negative and/or side effect.
The hair care composition of the present disclosure affects and/or works on multiple targets synergistically in the hair. The hair care composition simultaneously provides for disulphide bond formation, amide bond formation and boosting the level of amino acids in hair shaft, unlike known or commercially available hair care composition or treatment techniques which affect single targets.
In some embodiments of the present disclosure, the hair care composition comprises monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids.
In some embodiments of the present disclosure, the hair care composition comprises monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids.
In some embodiments of the present disclosure, the monounsaturated carboxylic acid is selected from a group comprising itaconic acid, maleic acid, patenedioic acid, hexedioic acid, hexenoic acid, octenedioic acid and any combinations thereof.
In some embodiments of the present disclosure, derivatives of the monounsaturated carboxylic acid are selected from a group comprising ester of monounsaturated carboxylic acid, isomer of monounsaturated carboxylic acid, amide of monounsaturated carboxylic acid, salt of monounsaturated carboxylic acid and any combinations thereof.
In an embodiment, the ester of the monounsaturated carboxylic acid is selected from a group comprising, Bis(2-ethylhexyl) maleate, dicaprylyl maleate, diethyl 2-butenedioate, diisostearyl fumarate and any combinations thereof.
In an embodiment, the amide of the monounsaturated carboxylic acid is selected from a group comprising maleamide, crotonamide, 3-butenamide and any combinations thereof.
In an embodiment, the salts of the monounsaturated carboxylic acid is selected from a group comprising Disodium maleate, disodium fumarate, sodium itaconate and any combinations thereof.
In an embodiment, the isomer of the monounsaturated carboxylic acid is selected from a group comprising Fumaric acid, mesaconic acid, citraconic acid and any combinations thereof.
In some embodiments of the present disclosure, the monounsaturated carboxylic acid is in an amount ranging from about 1% to 15%, including all the values in the range, for instance,
1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
In some embodiments of the present disclosure, derivatives of the monounsaturated carboxylic acid are in an amount ranging from about 1% to 15%, including all the values in the range, for instance, 1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
In some embodiments of the present disclosure, the transglutaminase (TGs) is selected from a group comprising TGI, TG2, TG3, TG4, TG5, TG6, TG7, Plasma TG and any combinations thereof.
In some embodiments of the present disclosure, the transglutaminase is in an amount ranging from about 0.001% to 1%, including all the values in the range, for instance, 0.002%, 0.003%, 0.004%, 0.005% and so on and so forth.
In some embodiments of the present disclosure, the amino acid blend comprises amino acids selected from a group comprising. Cysteine, Serine, Glutamic Acid, Threonine, Glycine, Leucine, Valine, Arginine, Aspartic Acid, Alanine, Proline, Isoleucine, Tyrosine, Phenylalanine, Histidine, Methionine, Lysine, Tryptophan and any combinations thereof.
In some embodiments of the present disclosure, the amino acid blend is selected from a group comprising blend of Alanine, Arginine, Proline, Tyrosine and Cysteine; blend of Cysteine, Histidine, Phenylalanine, Methionine and Isoleucine; blend of Glutamic acid, Arginine, Valine, Leucine and Alanine; blend of Aspartic Acid, Alanine, Proline, Arginine and Methionine; blend of Serine, Threonine, Glycine, Lysine and Tryptophan; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine and Isoleucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine and Phenylalanine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine and Methionine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine and Glutamic acid; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid and Leucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine and Valine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threonine; blend of Alanine,
Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine and Glycine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine and Aspartic Acid; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid and Isoleucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan.
In some embodiments of the present disclosure, the amino acid blend is in an amount ranging from about 0.05% to 10%, including all the values in the range, for instance, 0.06%, 0.07%, 0.08%, 0.09% and so on and so forth.
In some embodiments of the present disclosure, in the amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids, the amino acids are present in same proportion.
In some embodiments of the present disclosure, in the amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids, the amino acids are present in different proportions.
In some embodiments of the present disclosure, in the amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids, the amino acids are present in different proportions as present in virgin hair.
In some embodiments of the present disclosure, the composition comprises solvent includes but it is not limited to water. In an embodiment, the solvent is present in sufficient amount for making the composition, i.e., quantum sufficit (q.s.).
In some embodiments of the present disclosure, the composition comprises water in sufficient amount for making the composition, i.e., quantum sufficit (q.s.).
In an exemplary embodiment of the present disclosure, the composition comprises about 1% to about 15% of the monounsaturated carboxylic acid or its derivative; about 0.001% to 1% of the transglutaminase; about 0.05% to 10% of amino acid blend comprising at least 5 amino acids and solvent is present in sufficient quantity.
In another exemplary embodiment of the present disclosure, the composition comprises about 5% of the monounsaturated carboxylic acid or its derivative; about 1.0% of the amino acid blend comprising at least 5 amino acids; about 0.6% of the transglutaminase; and solvent is present in sufficient quantity.
In some embodiments of the present disclosure, the composition comprises chelating agent. In an embodiment, the chelating agent is selected from a group comprising Ethylenediaminetetraacetic acid, Disodium ethylenediaminetetraacetic acid, Trisodium Ethylenediamine Disuccinate, Dipotassium ethylenediaminetetraacetic acid, Diethyl oxalate and any combinations thereof.
In some embodiments of the present disclosure, the chelating agent is present in an amount ranging from about 0.05% to 1%, including all the values in the range, for instance, 0.06%. 0.07%, 0.08%, 0.09% and so on and so forth.
In an exemplary embodiment of the present disclosure, the chelating agent is present in an amount ranging from about 0.05% to 0.1%. In an embodiment, the chelating agent is present in an amount of about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09% or about 0.1%.
In some embodiments of the present disclosure, the composition has pH ranging from about 2 to 11, including all the values in the range, for instance, 2.1, 2.2, 2.3, 2.4 and so on and so forth.
The inventors of the present application have particularly identified that the combination of monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids provides for improved hair treatment and hair management, which is not observed while using components individually or a composition comprising combination of two components, respectively. The inventors have identified that the composition comprising combination of monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids, affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acid in hair shaft, which is not the case when the components are employed individually or a composition comprising combination of two components.
The figures 1 and 2 describes improved effect (as per SEM analysis) of the composition of the present disclosure in hair management and treatment, wherein surprising effect of the composition can be noted vis-a-vis individual components and composition comprising combination of two components, respectively. Similarly, Figure 3 describes improved effect (as per FT-IR analysis) of the composition of the present disclosure in hair management and treatment over individual components and composition comprising combination of two components, respectively.
The present disclosure further describes a method of preparing the composition described above.
In some embodiments of the present disclosure, the method of preparing the composition comprises- mixing the monounsaturated carboxylic acid or its derivative, the transglutaminase and the amino acid blend comprising at least 5 amino acids.
In some embodiments of the present disclosure, the method of preparing the composition comprises- mixing the monounsaturated carboxylic acid or its derivative, the transglutaminase and the amino acid blend comprising 5 amino acids, 6 amino acids, 7 amino acids, 8 amino acids, 9 amino acids, 10 amino acids, 11 amino acids, 12 amino acids, 13 amino acids, 14 amino acids, 15 amino acids, 16 amino acids, 17 amino acids or 18 amino acids.
In some embodiments of the present disclosure, the method of preparing the composition comprises: a) adding the monounsaturated carboxylic or its derivative to a mixture comprising the solvent and the chelating agent, followed by stirring; b) adding the transglutaminase, followed by stirring; and c) adding the amino acid blend comprising at least 5 amino acids and stirring to obtain the composition.
In an embodiment, the stirring in the step a) is carried out at a temperature ranging from about 20 °C to 60 °C, including all the values in the range, for instance, 21 °C, 22 °C, 23 °C, 24 °C and so on and so forth, for a duration ranging from about 1 minute to 90 minutes, including all the values in the range, for instance, 2 minutes, 3 minutes, 4 minutes, 5 minutes and so on and so forth. In an embodiment, the stirring is carried out until clear solution is obtained.
In an embodiment, the stirring in the step b) is carried out at a temperature ranging from about 20 °C to 60 °C, including all the values in the range, for instance, 21 °C, 22 °C, 23 °C, 24 °C and so on and so forth, for a duration ranging from about 1 minute to 60 minutes, including all the values in the range, for instance, 2 minutes, 3 minutes, 4 minutes, 5 minutes and so on and so forth. In an embodiment, the stirring is carried out until clear solution is obtained.
In an embodiment, the stirring in the step c) is carried out at a temperature ranging from about 20 °C to 60 °C, including all the values in the range, for instance, 21 °C, 22 °C, 23 °C, 24 °C and so on and so forth, for a duration ranging from about 1 minute to 90 minutes, including all the values in the range, for instance, 2 minutes, 3 minutes, 4 minutes, 5 minutes and so on and so forth.
In some embodiments, in the method of preparing the composition, upon adding the monounsaturated carboxylic acid or its derivative, the pH of the solution is maintained in a range of about 2 to 11, including all the values in the range, for instance, 2.1, 2.2, 2.3, 2.4 and so on and so forth.
The present disclosure further relates to a formulation comprising the composition described above in an effective amount.
In some embodiment, the formulation comprises the composition in an effective amount and excipient.
In some embodiments, in the formulation, the composition is present in an amount ranging from about 1% to 25%, including all the values in the range, for instance, 1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
In some embodiments, in the formulation, the excipient is present in an amount ranging from about 1% to 99%, including all the values in the range, for instance, 0.2%, 0.3%, 0.4%, 0.5% and so on and so forth.
In some embodiments, the excipient is selected from a group comprising Corrosion Inhibitors, Cosmetic Astringents, Denaturants, Deodorant Agents, Surfactant, Opacifiers, Chelating Agent, Emulsifier, Preservative, Thickeners, Emollient, Cosolvent, Abrasives, Anticaking Agent, Anticaries Agents, Antifoaming Agents, Antiperspirants, Antistatic Agents, Artificial Nail Builders, Depilating Agents, Bulking Agents, Colorants, Perfuming, Dispersing Agents, occlusive, Astringents, Emulsion Stabilizers, Epilating Agents, Exfoliants, Eyelash Conditioning Agents, Film Formers, Flavoring Agents, Fragrance Ingredients, Hair Colorants, Hair Conditioning Agents, Hair Fixatives, Hair Waving/Straightening Agents, Humectants, Light Stabilizers, Lytic Agents, Nail Conditioning Agents, Opacifying Agents, Oxidizing Agents, gelling agents and any combinations thereof.
In some embodiments, the formulation comprises solvent including but it is not limited to water. In an embodiment, the solvent is present in sufficient amount for making the composition, i.e., quantum sufficit (q.s.).
In some embodiments, the formulation has pH ranging from about 2 to 11, including all the values in the range, for instance, 2.1, 2.2, 2.3, 2.4 and so on and so forth.
In some embodiments, the formulation is selected from a group comprising Hair Mask, Hair Cream, Hair Spray, Hair Serum, Hair Colour, Hair Lotion, Hair Wax, Hair Gel, Hair Balm, Hair Mousse, Hair Tonic, Hair Moisturizer, Hair Cleanser, Hair Butter, Hair Colour Remover, Hair
Solution, Hair Pomade, Hair Volumizer, Hair Clay, Hair Cream, Hair Oil, Hair Stylers, Hair Heat Protector, Hair Conditioning Mask, Hair Root Pump, Dry Shampoo, Hair Texturizer, Hair Curl Retentioner, Heena Powder, Hair Growth Serum, Hair Drops, Hair Scalp Maintenance, Hair Scalp Exfoliator, Hair Scalp Scrub, Shampoo Bar, Conditioner Bar, Hair Concentrates and Hair Infusion.
The formulation of the present disclosure provides for improved hair management and hair treatment. The formulation affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acid in hair shaft. The formulation provides excellent hair management and treatment.
The present disclosure further relates to method for managing and/or treating hair.
In some embodiments of the present disclosure, the method for managing and/or treating hair comprises- applying the composition described above or the formulation described above to hair for managing and/or treating the hair.
In some embodiments of the present disclosure, in the method, the managing and/or treating of hair comprises at least one of hair damage repair, free cysteine rearrangement, amide bond repair, disulphide bond repair, keratin repair and any combinations thereof.
In some embodiments of the present disclosure, in the method, the managing and/or treating of hair comprises hair damage repair, free cysteine rearrangement, amide bond repair, disulphide bond repair and keratin repair.
In some embodiments of the present disclosure, in the method of managing and/or treating hair, the composition is employed at a concentration ranging from about 1% to 25%, including all the values the range, for instance, 1.1%, 1.2%, 1.3%, 1.4% and so on and so forth.
In some embodiments of the present disclosure, the managed and/or treated hair shows up to 95% reduction in free cysteine when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in free cysteine in the range of about 13% to 95%, including all the values in the range, for instance, 13%, 14%, 15%, 16% and so on and so forth, when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in free cysteine in the range of about 13% to 95%, including all the values in the range, for instance, 13%, 14%, 15%, 16% and so on and so forth, when compared to hair not applied with the composition or the formulation of the present disclosure.
In some embodiments of the present disclosure, the managed and/or treated hair shows up to about 81% reduction in combining force in wet hair when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in combining force in wet hair in the range of about 28% to 81%, including all the values in the range, for instance, 29%, 30%, 31%, 32% and so on and so forth, when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in combining force in wet hair in the range of about 28% to 81%, including all the values in the range, for instance, 29%, 30%, 31%, 32% and so on and so forth, when compared to hair not applied with the composition or the formulation of the present disclosure.
In some embodiments of the present disclosure, the managed and/or treated hair shows about 87% reduction in combining force in dry hair when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in combining force in dry hair in the range of about 46% to 87%, including all the values in the range, for instance, 47%, 48%, 49%, 50% and so on and so forth, when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows reduction in combining force in dry hair in the range of about 46% to 87%, including all the
values in the range, for instance, 47%, 48%, 49%, 50% and so on and so forth, when compared to hair not applied with the composition or the formulation of the present disclosure.
In some embodiments of the present disclosure, the managed and/or treated hair has increased tensile stress up to 48% when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair has tensile stress in the range of about 6% to 48%, including all the values in the range, for instance, 7%, 8%, 9%, 10% and so on and so forth. In an embodiment, the managed and/or treated hair applied with the composition or the formulation of the present disclosure has higher tensile stress when compared to bleached hair.
In some embodiments of the present disclosure, the managed and/or treated hair shows increased tensile stress in the range of about 6% to 48%, including all the values in the range, for instance, 7%, 8%, 9%, 10% and so on and so forth. In an embodiment, the managed and/or treated hair applied with the composition or the formulation of the present disclosure has higher tensile stress when compared to hair not applied with the composition or the formulation of the present disclosure.
In an embodiment, the Figure 1 provides Scanning electron microscopy (SEM) analysis images (500X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hairtreated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure. From the images, it can be noted that the bleaching of hair caused significant damage in the hair cuticles. It can be noted that when bleached hair was treated with individual components of the composition, hair showed negligible recovery from the damages caused by bleaching. Further, it can be noted that when the bleached hair was treated with composition comprising combination of two components there was only marginal recovery from the damages caused by bleaching. However, it was surprisingly noted that the bleached hair treated with the composition of the
present disclosure showed significant recovery from the damages caused by bleaching [see figure 1 (viii)]. It can be noted that cuticles of the hair were found be repaired with smooth texture. Thus, clearly establishing that the composition of the present disclosure has synergistic effect in treating and/or managing hair.
In an embodiment, the Figure 2 provides Scanning electron microscopy (SEM) analysis images (1000X magnification) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hairtreated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure. From the images, it can be noted that the bleaching of hair caused significant damage in the hair cuticles. It can be noted that when bleached hair was treated with individual components of the composition, hair showed negligible recovery from the damages caused by bleaching. Further, it can be noted that when the bleached hair was treated with composition comprising combination of two components there was only marginal recovery from the damages caused by bleaching. However, it was surprisingly noted that the bleached hair treated with the composition of the present disclosure showed significant recovery from the damages caused by bleaching [see figure 2 (viii)]. It can be noted that cuticles of the hair were found be repaired with smooth texture. Thus, clearly establishing that the composition of the present disclosure has synergistic effect in treating and/or managing hair.
In an embodiment, the Figure-3 provides Fourier-transform infrared spectroscopy (FT-IR) analysis plot of- i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hairtreated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure. From the FT-IR spectrum,
it can be noted that, the bleached hair showed a peak at 1042 cm 1 which attributes to the presence of cysteic acid. Furthermore, same peak was observed between 1045-1040 cm 1 in the FT-IR spectrum of hair treated with individual components of the composition and combination of two components. However, this peak is absent in the spectra of hair treated with the composition of the present disclosure suggested absence of cysteic acid.
The composition, the formulation and the method of managing and treating hair of the present disclosure provides for the following advantages.
The composition and/or the formulation affects and/or works on multiple targets simultaneously and synergistically, such as disulphide bond formation, amide bond formation and boosting the level of amino acid in hair shaft.
The composition and/or the formulation of the present disclosure provides for hair damage repair, free cysteine rearrangement, amide bond repair, disulphide bond repair, keratin repair, hair detangling, frizz control and hair softness.
It is to be understood that the foregoing description is illustrative not a limitation. While considerable emphasis has been placed herein on particular features of this disclosure, it will be appreciated that various modifications can be made, and that many changes can be made in the preferred embodiments without departing from the principles of the disclosure. Those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein. Similarly, additional embodiments and features of the present disclosure will be apparent to one of ordinary skill in art based upon description provided herein.
Descriptions of well-known/conventional methods/steps and techniques are omitted so as to not unnecessarily obscure the embodiments herein. Further, the disclosure herein provides for examples illustrating the above-described embodiments, and in order to illustrate the embodiments of the present disclosure, certain aspects have been employed. The examples used herein for such illustration are intended merely to facilitate an understanding of ways in which the embodiments may be practiced and to further enable those of skill in the art to practice the embodiments. Accordingly, following examples should not be construed as limiting the scope of the embodiments herein.
EXAMPLES
Example 1: Preparation of the Composition
About 98.6 gm water and about 0.1 chelating agent were mixed to obtain a solution. To the solution, about 1% of Maleic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4-5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine and Cysteine was added and stirred to obtain the composition.
Example 2: Preparation of the Composition
About 96.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution about 3% of Itaconic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4-5. About O.lgm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2g of amino acid blend comprising Cysteine, Histidine, Phenylalanine, Methionine and Isoleucine was added and stirred to obtain the composition.
Example 3: Preparation of the Composition
About 96.6 gm water and about 0.1 gm chelating agent are mixed to obtain a solution. To the solution about 3% of fumaric acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4-5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 of amino acid blend comprising Glutamic acid, Arginine, Valine, Leucine and Alanine was added and stirred to obtain the composition.
Example 4: Preparation of the Composition
About 89.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution about 10 gm of hexenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4-5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Aspartic Acid, Alanine, Proline, Arginine and Methionine was added and stirred to obtain the composition.
Example 5: Preparation of the Composition
About 84.6 gm water and about O.lgm chelating agent were mixed to obtain a solution. To the solution about 15 gm of Octenedioc acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4-5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2gm of amino acid blend comprising Serine, Threonine, Glycine, Lysine and Tryptophan was added and stirred to obtain the composition.
Example 6: Preparation of the Composition
About 96.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 3 gm of Itaconic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine was added and stirred to obtain the composition.
Example 7: Preparation of the Composition
About 98.3 gm water and about 0.1 g chelating agent were mixed to obtain a solution. To the solution, about 1 gm of Maleic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.5 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine; was added and stirred to obtain the composition.
Example 8: Preparation of the Composition
About 96.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 3 gm of Fumaric acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine was added and stirred to obtain the composition.
Example 9: Preparation of the Composition
About 89.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 10 gm of Hexenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine was added and stirred to obtain the composition.
Example 10: Preparation of the Composition
About 84.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 15 gm of Octenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine was added and stirred to obtain the composition.
Example 11: Preparation of the Composition
About 96.3 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 3 gm of Itaconic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.5 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine and Glutamic acidwas added and stirred to obtain the composition.
Example 12: Preparation of the Composition
About 94.2 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 5 gm of Maleic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.2 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.5 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine,
Phenylalanine, Histidine, Methionine and Glutamic acidwas added and stirred to obtain the composition.
Example 13: Preparation of the Composition
About 93.8 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 5 gm of Fumaric acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 1 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine and Glutamic acid was added and stirred to obtain the composition.
Example 14: Preparation of the Composition
About 88.7 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 10 gm of Hexenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.2 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 1 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine and Glutamic acid was added and stirred to obtain the composition.
Example 15: Preparation of the Composition
About 82.7 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 15 gm of Octenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.2 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine and Glutamic acidwas added and stirred to obtain the composition.
Example 16: Preparation of the Composition
About 96.7 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 1 gm of Itaconic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.2 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threonine was added and stirred to obtain the composition.
Example 17: Preparation of the Composition
About 93.7 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 3 gm of Maleic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.2 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 3 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threonine was added and stirred to obtain the composition.
Example 18: Preparation of the Composition
About 91.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 5 gm of Fumaric acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.3 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 3 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threoninewas added and stirred to obtain the composition.
Example 19: Preparation of the Composition
About 85.5 gm water and about 0.1 gm chelating agent are mixed to obtain a solution. To the solution, about 10 gm of Hexenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.4 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 4 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine,
Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threoninewas added and stirred to obtain the composition.
Example 20: Preparation of the Composition
About 79.4 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 15 gm of Octenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.5 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 5 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threoninewas added and stirred to obtain the composition.
Example 21: Preparation of the Composition
About 93.4 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 1 gm of Itaconic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.5 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 5 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophanwas added and stirred to obtain the composition.
Example 22: Preparation of the Composition
About 96.6 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 3 gm of Maleic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.2 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophanwas added and stirred to obtain the composition.
Example 23: Preparation of the Composition
About 93.3 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 5 gm of Fumaric acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.8 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.8 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan was added and stirred to obtain the composition.
Example 24: Preparation of the Composition
About 88.3 gm water and about 0.1 gm chelating agent were mixed to obtain a solution. To the solution, about 10 gm of Hexenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 0.8 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 0.8 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan was added and stirred to obtain the composition.
Example 25: Preparation of the Composition
About 73.9 gm water and about 0.1 gm chelating agent are mixed to obtain a solution. To the solution, about 15 gm of Octenedioic acid was added, followed by stirring until clear solution was obtained. Further, pH of the solution was adjusted to about 4 - 5. About 1 gm transglutaminase was added, followed by stirring until clear solution was obtained. About 10 gm of amino acid blend comprising Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan was added and stirred to obtain the composition.
Example 26: Preparation of the Formulation
Formulations obtained according to the compositions of the present disclosure are provided below
Formulation for Hair Mask:
Formulation for Hair Shampoo:
Formulation for Hair Serum:
Example 27: Comparative Example
In this example, the hair is treated with- i. the composition of the present disclosure; ii. individual components (maleic acid, amino acid blend comprising at least 5 amino acids, transglutaminase, respectively); and iii. composition comprising combination of two components, independently- a) maleic acid and amino acid blend comprising at least two amino acids
b) transglutaminase and amino acid blend comprising at least two amino acids; and c) maleic acid and transglutaminase bleached was used control
Table 1:
The data in Table 1 demonstrates that the hair treated with the composition of the present disclosure has significantly reduced cysteine content when compared to hair treated with individual components and hair treated with composition comprising combination of two components (SI. No. 2, 3 and 4). From the data in the Table 1 it can be inferred that the composition of the present disclosure has higher efficacy to keep the disulfide bond aligned and intact in the hair fibres, thus leading to significantly reduced free cysteine content, when compared to composition comprising combination of two components. According to scanning electron microscopy, no effect was noted when individual components for the composition were applied separately.
It must be noted that higherthe amount of free cysteine in hair represents higher the damage level of the hair fibre.
Combining Force:
Combining force represents cuticle alignment of hair fibres. Lower the combining force means more aligned unidirectional cuticle, i.e., improved managing of hair.
Table 2:
Data in Table 2 demonstrates that the hair treated with the composition of the present disclosure has significantly reduced combining force, implying that the hair has higher aligned unidirectional cuticle when compared to hair treated with individual components and composition comprising combination of two components (Sr. No. 2, 3 and 4), respectively. According to scanning electron microscopy, no effect was noted when individual components were applied separately.
Tensile Stress:
Tensile stress or break stress represents overall strength of the hair fibres. Higher the tensile stress/ break stress means higher the tensile strength and less fragility of hair fibres.
Table 3:
Data in Table 3 demonstrates that the hair treated with the composition of the present disclosure has significantly higher tensile stress which attributes to increased tensile strength and lower fragility of hair when compared to hair treated with composition comprising combination of two components (Sr. No. 2, 3 and 4), respectively.
FT-IR Analysis:
Figure 3 shows FT-IR spectrums of- i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
Table 4: i. The FT-IR spectrum of bleached hair and hair treated with individual components and composition comprising combination of two components, showed a peak between 1045-1040 cm 1 which represent the presence of cysteic acid. While the hair treated with the composition of the present disclosure did not show peak between 1045-1041 cm4. Thus, it was noted that the composition of the present disclosure showed improved efficacy in converting free cysteine into the cystine (disulphide bonding), as a result free cysteine would not be available to oxidize into cysteic acid in the hair treated with the composition of the present disclosure. ii. The FT-IR spectrum of bleached hair and hair treated with individual components and composition comprising combination of two components, showed a peak
between 1115-1089 cm 1 which represent conversion of free cysteine to its sulphur monoxide derivative. While the hair treated with the composition of the present disclosure did not show peak between 1115-1089 cm 1 along with the cysteic acid peak (~1040 cm ) as mentioned above. This implying that there was no conversion of free cysteine to cysteic acid in the hair treated with the composition of present disclosure. iii. The FT-IR spectrum of bleached hair and hair treated with the individual components and composition comprising combination of two components showed a sharp peak between 1739-1738 cm 1 which represents the deformation of amide bonds. The intensity of this peak decreased drastically in the FT-IR spectra of hair treated with the composition of the present disclosure, implying that there was insignificant or no amide bond deformation. iv. The FT-IR spectrum of bleached hair and hair treated with individual components and a composition comprising combination of two components showed peaks between 1388-1365 & 1220-1215 cm 1 which represent the presence of SO2 functionality that is due to the conversion of free cysteine to cysteic acid in the hair. The intensity of these peaks decreased significantly in the FT-IR spectra of hair treated with the composition of the present disclosure, implying that there was remarkably less conversion of free cysteine to cysteic acid.
Figures 1 and 2 provides SEM analysis images (500X and 1000X magnification, respectively) of i. bleached hair; ii. hair treated with amino acid; iii. hair treated with monounsaturated carboxylic acid (e.g., maleic acid); iv. Hair treated with transglutaminase; v. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and amino acid blend comprising at least 5 amino acids; vi. hair treated with combination of amino acid blend comprising at least 5 amino acids and transglutaminase; vii. hair treated with combination of monounsaturated carboxylic acid (e.g., maleic acid) and transglutaminase; and viii. hair treated with the composition of the present disclosure.
From the SEM images it can be noted that-
Bleached hair showed damaged cuticles.
Hair treated with individual components and composition comprising combination of two components continued to show damaged cuticles, respectively.
Hair treated with the composition of the present disclosure showed complete cuticle repair.
Additional embodiments and features of the present disclosure will be apparent to one of ordinary skill in art based on the description provided herein. The embodiments herein provide various features and advantageous details thereof in the description. Descriptions of well-known/conventional methods and techniques are omitted so as to not unnecessarily obscure the embodiments herein.
The foregoing description of the specific embodiments fully reveals the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is forthe purpose of description and not of limitation. Therefore, while the embodiments in this disclosure have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein.
As regards the embodiments characterized in this specification, it is intended that each embodiment be read independently as well as in combination with another embodiment. For example, in case of an embodiment 1 reciting 3 alternatives A, B and C, an embodiment 2 reciting 3 alternatives D, E and F and an embodiment 3 reciting 3 alternatives G, H and I, it is to be understood that the specification unambiguously discloses embodiments corresponding to combinations A, D, G; A, D, H; A, D, I; A, E, G; A, E, H; A, E, I; A, F, G; A, F, H; A, F, I; B, D, G; B, D, H; B, D, I; B, E, G; B, E, H; B, E, I; B, F, G; B, F, H; B, F, I; C, D, G; C, D, H; C, D, I; C, E, G; C, E, H; C, E, I; C, F, G; C, F, H; C, F, I, unless specifically mentioned otherwise.
While considerable emphasis has been placed herein on the particular features of this disclosure, it will be appreciated that various modifications can be made, and that many changes can be made in the preferred embodiments without departing from the principles of
the disclosure. These and other modifications in the nature of the disclosure or the preferred embodiments will be apparent to those skilled in the art from the disclosure herein, whereby it is to be distinctly understood that the foregoing descriptive matter is to be interpreted merely as illustrative of the disclosure and not as a limitation.
Claims
1. A composition comprising- monounsaturated carboxylic acid or its derivative, transglutaminase and amino acid blend comprising at least 5 amino acids.
2. The composition as claimed in claim 1, wherein the monounsaturated carboxylic acid or its derivative is selected from a group comprising itaconic acid, butenedioc acid, pentenedioc acid, hexenedioc acid, maleic acid, hexenoic acid, octeneoic acid, Bis(2- ethylhexyl) maleate, maleamide and any combinations thereof.
3. The composition as claimed in claim 1, wherein the transglutaminase (TGs) is selected from a group comprising TGI, TG2, TG3, TG4, TG5, TG6, TG7, Plasma TG and any combination thereof.
4. The composition as claimed in claim 1, wherein the amino acid blend comprises amino acids selected from a group comprising Cysteine, Serine, Glutamic Acid, Threonine, Glycine, Leucine, Valine, Arginine, Aspartic Acid, Alanine, Proline, Isoleucine, Tyrosine, Phenylalanine, Histidine, Methionine, Lysine, Tryptophan and any combinations thereof.
5. The composition as claimed in claim 1, wherein the amino acid blend is selected from a group comprising blend of Alanine, Arginine, Proline, Tyrosine and Cysteine; blend of Cysteine, Histidine, Phenylalanine, Methionine and Isoleucine; blend of Glutamic acid, Arginine, Valine, Leucine and Alanine; blend of Aspartic Acid, Alanine, Proline, Arginine and Methionine; blend of Serine, Threonine, Glycine, Lysine, Tryptophan blend of Alanine, Arginine, Proline, Tyrosine, Cysteine and Isoleucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine and Phenylalanine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine and Histidine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine and Methionine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine and Glutamic acid; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid and Leucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine and Valine;
blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine and Threonine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine and Glycine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine and Aspartic Acid; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid and Isoleucine; blend of Alanine, Arginine, Proline, Tyrosine, Cysteine, Isoleucine, Phenylalanine, Histidine, Methionine, Glutamic acid, Leucine, Valine, Threonine, Glycine, Aspartic Acid, Isoleucine and Tryptophan. The composition as claimed in claim 1, wherein the monounsaturated carboxylic acid is in an amount ranging from about 1% to 15%. The composition as claimed in claim 1, wherein the transglutaminase is in an amount ranging from about 0.001% to 1%. The composition as claimed in claim 1, wherein the amino acid blend is in an amount ranging from about 0.05% to 10%. The composition as claimed in claim 1, wherein the composition further comprises chelating agent selected from a group comprising Ethylenediaminetetraacetic acid, Disodium ethylenediaminetetraacetic, Trisodium Ethylenediamine Disuccinate, Dipotassium ethylenediaminetetraacetic acid, Diethyl oxalate and any combinations thereof; and wherein the chelating agent is in an amount ranging from about 0.05% to 1%. The composition as claimed in claim 1, wherein the composition comprises water q.s. (quantum sufficit). A method of preparing the composition as claimed in claim 1, said method comprises- mixing the monounsaturated carboxylic acid or its derivative, the transglutaminase and the amino acid blend comprising at least 5 amino acids to obtain the composition.
The method as claimed in claim 11, wherein the method comprises adding the monounsaturated carboxylic acid to mixture of chelating agent and water, followed by adding the transglutaminase and the amino acid blend comprising at least 5 amino acids. A formulation comprising the composition as claimed in claim 1. The formulation as claimed in claim 13, wherein the composition is in an amount ranging from about 1% to 25%. The formulation as claimed in claim 13, wherein the formulation comprises excipient in an amount ranging from about 1% to 99%; and wherein the excipient is selected from a group comprising Corrosion Inhibitors, Cosmetic Astringents, Cosmetic Biocides, Denaturants, Deodorant Agents, Surfactant, opacifiers chelating agent, emulsifier, preservative, thickeners, emollient, solvents, cosolvent, abrasives, anticaking agent, anticaries agents, antifoaming agents, antiperspirants, antistatic agents, artificial nail builders, Depilating Agents, bulking agents, colorants, perfuming, Dispersing Agents, occlusive, Astringents, Emulsion Stabilizers, Epilating Agents, Exfoliants, Eyelash Conditioning Agents, Film Formers, Flavouring Agents, Fragrance Ingredients, Hair Colorants, Hair Conditioning Agents, Hair Fixatives, Hair- Waving/Straightening Agents, Humectants, Light Stabilizers, Lytic Agents, Nail Conditioning Agents, Opacifying Agents, Oxidizing Agents, gelling agents and any combinations thereof. The formulation as claimed in claim 13, wherein the formulation is selected from a group comprising Hair mask, Hair Cream, Hair Spray, Hair Serum, Hair Colour, Hair Lotion, Hair Wax, Hair Gel, Hair Balm, Hair Mousse, Hair Tonic, Hair Moisturizer, Hair Cleanser, Hair Butter, Hair Colour Remover, Hair Solution, Hair Pomade, Hair Volumizer, Hair Clay, Hair Cream Oil, Hair Stylers, Hair Heat Protector, Hair Conditioning Mask, Hair Root Pump, Dry Shampoo, Hair Texturizer, Hair Curl Retentioner, Heena Powder, Hair Growth Serum, Hair Drops, Hair Scalp Maintenance, Hair Scalp Exfoliator, Hair Scalp Scrub, Shampoo Bar, Conditioner Bar, Hair Concentrates and Hair infusion.
A method for managing and/or treating hair, said method comprises applying the composition as claimed in claim 1 or the formulation as claimed in claim 14 to hair for managing and/or treating the hair. The method as claimed in claim 17, wherein the managing hair comprises Hair damage repairing, free Cysteine rearrangement, amide bond repair, disulfide bond repair, keratin repair and any combination thereof. The method as claimed in claim 17, wherein the composition is at a concentration ranging from about 1% to 25. The method as claimed in claim 17, wherein the managed hair shows reduction in free cysteine content in the range of about 13% to 95%. The method as claimed in claim 17, wherein the managed hair shows reduction in combining force in the range of about 28% to 81% for wet hair and shows reduction in combining force in the range of about 46% to 87% for dry hair. The method as claimed in claim 17, wherein the managed hair has tensile stress ranging from about 6% to 48%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202211068383 | 2022-11-28 | ||
IN202211068383 | 2022-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024116027A1 true WO2024116027A1 (en) | 2024-06-06 |
Family
ID=91323065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2023/061790 WO2024116027A1 (en) | 2022-11-28 | 2023-11-22 | Hair care composition, a formulation and method of treating and managing hair |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024116027A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490980A (en) * | 1994-09-28 | 1996-02-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Covalent bonding of active agents to skin, hair or nails |
WO2001021139A2 (en) * | 1999-09-22 | 2001-03-29 | Henkel Kommanditgesellschaft Auf Aktien | Method for restructuring keratin fibers using an enzyme of the transglutaminase type |
WO2013184463A1 (en) * | 2012-06-04 | 2013-12-12 | Elc Management Llc | Compositions and methods for enhancing the structure of hair fibers |
US9498419B2 (en) * | 2014-05-16 | 2016-11-22 | Liqwd, Inc. | Keratin treatment formulations and methods |
-
2023
- 2023-11-22 WO PCT/IB2023/061790 patent/WO2024116027A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490980A (en) * | 1994-09-28 | 1996-02-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Covalent bonding of active agents to skin, hair or nails |
WO2001021139A2 (en) * | 1999-09-22 | 2001-03-29 | Henkel Kommanditgesellschaft Auf Aktien | Method for restructuring keratin fibers using an enzyme of the transglutaminase type |
WO2013184463A1 (en) * | 2012-06-04 | 2013-12-12 | Elc Management Llc | Compositions and methods for enhancing the structure of hair fibers |
US9498419B2 (en) * | 2014-05-16 | 2016-11-22 | Liqwd, Inc. | Keratin treatment formulations and methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4660580A (en) | Process for the permanent shaping of the regrowth of hair and composition therefore | |
JP2020527600A (en) | Composition for straightening curly hair | |
US8785370B2 (en) | Reactive keratin protein formulations and methods of using for revitalizing hair | |
US20070116661A1 (en) | Hair restorative compositions and methods for treating damaged hair and safely chemically treating hair | |
WO2019016977A1 (en) | Hair cosmetic composition, hair colorant composition, and hair color treatment method | |
KR20120095321A (en) | Hair treatment | |
JP2015214511A (en) | Chemical composition | |
WO2014065274A1 (en) | Permanent solution and hair conditioning agent | |
JP6799096B2 (en) | Treatment composition for healing damaged hair using cystamine derivatives | |
WO2024116027A1 (en) | Hair care composition, a formulation and method of treating and managing hair | |
JP5738143B2 (en) | Hair treatment agent and hair treatment method | |
JP6980438B2 (en) | Hair color treatment method | |
JP2016094360A (en) | Chemical composition | |
TWI832834B (en) | A hair color process | |
KR101728306B1 (en) | Composition for protection of hair and hair permanent composition including composition thereof | |
EA012881B1 (en) | Cosmetic composition with increasedho content | |
JPH04342518A (en) | Hair dyeing agent | |
WO2020079857A1 (en) | Hair colorant composition | |
JP2001220321A (en) | Hair appearance-improving agent | |
JP5788372B2 (en) | Perm solution and hair conditioner | |
JP5592063B2 (en) | Hair component spill prevention agent | |
JPH0469319A (en) | Hair-treating agent | |
JP7112698B2 (en) | Hair coloring agent composition | |
JP7111365B2 (en) | hair color method | |
TWI835137B (en) | Hair bleaching compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23896995 Country of ref document: EP Kind code of ref document: A1 |